Kunal Desai

Cerity Partners Ventures is the corporate venture practice of Cerity Partners. We help corporations work with innovative startups, with the goal of fueling their mutual success. ​ ​Founded as Touchdown Ventures in 2014, our team brings an impact orientation to every relationship. We are dedicated to providing critical insights and transactions to help corporations adapt to the rapid pace of change in todays market.​ ​Cerity Partners Ventures seeks venture capital investments on behalf of our corporate partners in sectors that can be found here: www.ceritypartners.com/ventures.

Cerity Partners Ventures is the corporate venture practice of Cerity Partners. We help corporations work with innovative startups, with the goal of fueling their mutual success. ​ ​Founded as Touchdown Ventures in 2014, our team brings an impact orientation to every relationship. We are dedicated to providing critical insights and transactions to help corporations adapt to the rapid pace of change in todays market.​ ​Cerity Partners Ventures seeks venture capital investments on behalf of our corporate partners in sectors that can be found here: www.ceritypartners.com/ventures.

Revere Partners is the first-ever venture capital fund focused on oral health—identifying opportunities for investors, providing capital for cutting-edge innovations in the oral and systemic health sectors. Revere is changing the landscape of dental and systemic health ventures, bringing market awareness, business acumen, and the top minds in the field together to elevate innovations and optimize both patient and provider experience. Revere can lead or follow, priced round or not. A strategic, active investor and thought leader, Revere provides the essential combination of dental industry expertise and analytical data research capabilities to predict trends and opportunities within the healthcare industry. Founders Dr. Jeremy Krell and David Arena have built an all-star 25+ person management team to connect startups with leadership at the top dental chains, manufacturers, distributors, insurers, academics, professional associations, nationwide labs and retailers. With a mission to educate and create better outcomes, Revere compiled an unrivaled data set of dental technology companies. Revere’s data and track record also highlight the value of focusing on Seed and Series A rounds. In addition, the company has carved a space in their portfolio for small allotments to special opportunities such as pre-seed and innovation competitions, and follow-on investments (Series B and beyond). Investment targets include software, fintech, technology/diagnostics, dental services/biotech, consumer/brands, payments/reimbursement and access to care. Revere helps foster unrivaled strategic partnerships that will improve care delivery, as well as patient and providers experiences—maximizing value for investors.